Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Glycemic Control After Reperfusion on Acute Kidney Injury in Living Donor Liver Transplantation: A Propensity Score-matched Analysis

NCT06320730 is registered in ClinicalTrials.gov with Asan Medical Center as lead sponsor.

NCT NCT06320730
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06320730 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Glycemic Control After Reperfusion on Acute Kidney Injury in Living Donor Liver Transplantation: A Propensity Score-matched Analysis
Lead sponsor
Asan Medical Center
Phase
Observational
Overall status
Completed
Start date
August 25, 2020
Completion date
March 1, 2021
Enrollment
3,790 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute kidney injury, end stage liver disease, hyperglycemia, hypoglycemia